related documents
- Mo1653 Improvement of Gastrointestinal Symptoms After Gluten-Free Diet in Patients With Irritable Bowel Syndrome Is Dependent on the Presence of Anti-Gliadin Antibodies Conference Paper
- Mo1773 Variation in the Treatment of New Onset Pediatric IBD Among Phenotypically Similar Patient Subgroups in Canada: A Cross-Sectional Analysis of the Canadian Children IBD Network Inception Cohort Conference Paper
- Sa1398 Immunogenic Gluten Is Modulated by Small Intestinal Bacterial Hydrolysis Conference Paper
- Sa1888 Efficacy and Predictors of Outcomes of Vedolizumab for Ulcerative Colitis in Clinical Practice Conference Paper
- Sa1889 Efficacy and Predictors of Outcomes of Vedolizumab for Crohn's Disease in Clinical Practice Conference Paper
- Su1012 Canadian Patient and Caregiver Perspectives on Subsequent Entry Biologics/Biosimilars for Inflammatory Bowel Disease Conference Paper
- Su1393 Does Giving Pasireotide to Patients Undergoing Pancreaticoduodenectomy Pay for Itself? Conference Paper
- Su1891 Colonization of Germ-Free Mice With Human Derived Microbiota Induces Progressive Ultrastructural, Innate, and Functional Changes in the Intestinal Barrier Conference Paper
- Su1901 High Salt Diet Increases Susceptibility to Experimental Colitis: A Putative Role of Gut Microbiota Conference Paper
- Tu1068 Diarrhea in the Intensive Care Unit: Epidemiology (The DICE Study) Conference Paper
- Tu1908 Safety of Vedolizumab in Inflammatory Bowel Disease in a Multi-Center Real World Consortium Conference Paper